Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLA1 | P09884 | 1/20 | 0.70 |
| ▸ | CYP46A1 | Q9Y6A2 | 2/20 | 0.69 |
| ▸ | USP2 | O75604 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.65 |
| ▸ | OSBP | P22059 | 1/20 | 0.65 |
| ▸ | RORC | P51449 | 1/20 | 0.65 |
| ▸ | OSBP2 | Q969R2 | 1/20 | 0.65 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.62 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.58 |
| ▸ | NPC1L1 | Q9UHC9 | 1/20 | 0.58 |
| ▸ | GBA1 | P04062 | 2/20 | 0.58 |
| ▸ | UGCG | Q16739 | 2/20 | 0.58 |
| ▸ | GBA2 | Q9HCG7 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL190539 | 1.00 | POLA1 (0.70) | POLA1CYP46A1USP2LMNAABCB1 | |
| SCHEMBL161747 | 1.00 | POLA1 (0.70) | POLA1CYP46A1USP2LMNAABCB1 | |
| SCHEMBL767706 | 1.00 | POLA1 (0.70) | POLA1CYP46A1USP2LMNAABCB1 | |
| SCHEMBL162885 | 1.00 | POLA1 (0.70) | POLA1CYP46A1USP2LMNAABCB1 | |
| SCHEMBL22620094 | 1.00 | POLA1 (0.70) | POLA1CYP46A1USP2LMNAABCB1 | |
| SCHEMBL21177689 | 1.00 | POLA1 (0.70) | POLA1CYP46A1USP2LMNAABCB1 | |
| SCHEMBL140321 | 1.00 | POLA1 (0.70) | POLA1CYP46A1USP2LMNAABCB1 | |
| SCHEMBL18006649 | 1.00 | POLA1 (0.70) | POLA1CYP46A1USP2LMNAABCB1 | |
| SCHEMBL295638 | 1.00 | POLA1 (0.70) | POLA1CYP46A1USP2LMNAABCB1 | |
| SCHEMBL9436821 | 1.00 | POLA1 (0.70) | POLA1CYP46A1USP2LMNAABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 906 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12233034-B2 | Formulations for epidermal repair | CLARIDEI LABORATORIES, INC. (US) | 2025-02-25 | — | — | US | claimed |
| CN-119499247-A | Double-drug-carrying recombinant high-density lipoprotein nanoparticle for improving or treating intestinal inflammation and preparation method and application thereof | 中国农业大学 | 2025-02-25 | — | — | CN | claimed |
| CN-118141908-A | Lymph targeting tumor nano vaccine and application thereof | 中国药科大学 | 2024-06-07 | — | — | CN | claimed |
| CN-117597118-A | Pharmaceutical composition for preventing or treating viral infection comprising as active ingredient a crude drug | QVET公司 | 2024-02-23 | — | — | CN | claimed |
| CN-117098536-A | Composition containing antitumor drug and preparation method and application thereof | 昆山新蕴达生物科技有限公司 | 2023-11-21 | — | — | CN | claimed |
| WO-2023061393-A1 | COMPOSITION CONTAINING ANTITUMOR DRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 昆山新蕴达生物科技有限公司 | 2023-04-20 | — | — | WO | claimed |
| CN-115919771-A | Reverse phospholipid liposome assembly and preparation method thereof | 于喜飞 | 2023-04-07 | — | — | CN | claimed |
| CN-115461096-A | Polymer encapsulated drug particles | 吉益医疗公司 | 2022-12-09 | — | — | CN | claimed |
| EP-4025660-A1 | THERMOCHROMIC LIQUID CRYSTAL INKS AND COATINGS | Sun Chemical Corporation (US) | 2022-07-13 | — | — | EP | claimed |
| CN-114526968-A | Preparation and use method of skin bionic dirt | 北京颐唯实检测技术有限公司 | 2022-05-24 | — | — | CN | claimed |
| EP-0797433-A1 | GAS FILLED MICROSPHERES AS MAGNETIC RESONANCE IMAGING CONTRAST AGENTS | ImaRx Pharmaceutical Corp. (US) | 1997-10-01 | — | — | EP | claimed |
| EP-0760684-A1 | GAS FILLED MICROSPHERES AS COMPUTED TOMOGRAPHY CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 1997-03-12 | — | — | EP | claimed |
| EP-0740528-A1 | GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION | IMARX PHARMACEUTICAL CORP. (US) | 1996-11-06 | — | — | EP | claimed |
| WO-1995032006-A1 | GAS FILLED MICROSPHERES AS COMPUTED TOMOGRAPHY CONTRAST AGENTS | IMARX, PHARMACEUTICAL CORP. (US) | 1995-11-30 | — | — | WO | claimed |
| WO-1995024184-A1 | GAS FILLED MICROSPHERES AS MAGNETIC RESONANCE IMAGING CONTRAST AGENTS | UNGER EVAN C (US) | 1995-09-14 | — | — | WO | claimed |
| WO-1995015118-A1 | GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION | IMARX PHARMACEUTICAL CORP. (US) | 1995-06-08 | — | — | WO | claimed |
| EP-0367788-A1 | RECEPTOR-BASED BIOSENSORS | ARTHUR D. LITTLE, INC. (US) | 1990-05-16 | — | — | EP | claimed |
| WO-1988009808-A2 | RECEPTOR-BASED BIOSENSORS | ARTHUR D. LITTLE, INC. (US) | 1988-12-15 | — | — | WO | claimed |
| US-4397839-A | RESPIRATORY DISTRESS SYNDROME | TOKYO TANABE COMPANY, LIMITED (JP) | 1983-08-09 | — | — | US | claimed |
| US-4011138-A | FERMENTATION OF PSEUDOMONAS | KYOWA HAKKO KOGYO CO., LTD. (JA) | 1977-03-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12233034-B2 | Formulations for epidermal repair | KRT18, CUTA, DSG1 | POLA1 2900/4885CYP46A1 1451/4885USP2 1927/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.